 |
New finding may do away with insulin injectionAustralian scientists have discovered how insulin is taken up by cells, potentially opening the way for new drugs for diabetes patients that can be administered without injection. The team, whos More… |
 |
Bahrain to set up $93m insulin plantBahrain is to set up an insulin production plant at a cost of BD35 million ($93 million) in line with its strategy to supply lifesaving products to people with diabetes across the Gulf region. The Gulf Biotic facility will be constructed o More… |
 |
Infant diabetes ‘rising in Bahrain’The number of babies with diabetes, who require insulin from birth, has tripled in Bahrain in the last 20 years, according to a health expert. Latest figures show that 25 out of 100,000 babies were born with type one insulin dependent Diab More… |
 |
Onglyza reduces blood sugar levels: studyPharmaceutical companies Bristol-Myers Squibb and AstraZeneca have announced results from an investigational phase 3b clinical study of use of Onglyza (saxagliptin) in diabetic patients. The study was based on the addition of Onglyza (saxa More… |
 |
Insulin releasing switch discoveredThe molecular switch for the secretion of insulin — the hormone that regulates blood sugar — has been uncovered, providing for the first time an explanation of this process, said a report. In a report published online recently in Cell Meta More… |
 |
Boehringer, Eli Lilly in major diabetes drugs dealBoehringer Ingelheim and Eli Lilly and Company today announced a global agreement to jointly develop and commercialise a portfolio of diabetes compounds currently in mid- and late-stage development. Included are Boehringer Ingelheim’s two More… |
 |
Link seen between diabetes, bone massInsulin, the sugar-regulating hormone, is required for normal bone development and it may provide a link between bone health and metabolic disease, such as diabetes, said a report. The study, headed by Thomas Clemens, PhD, the Lewis Cass S More… |
 |
Sanofi-aventis' new insulin injection more efficientSanofi-aventis has announced the results of new analysis that found a significantly lower risk of nocturnal hypoglycemia with Lantus (insulin glargine [rDNA] injection) as compared to NPH insulin. A separate post-hoc sub-analysis found a g More… |
 |
Sanofi-aventis drug wins EMA clearanceSanofi-aventis, a leading global pharmaceutical company, has confirmed that changes to the prescribing advice of its new insulin injection are not necessary following a review of the drug by a committee of the European Medicines Agency (EMA). More… |
Bahrain plans $2.5m diabetes study centreBahraini health officials have announced plans to set up a new BD1-million ($2.5 million) diabetes education centre to focus on diabetes education and rehabilitation. More… |
